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Abstract.  Syndecan-1 is a cell surface heparan sulfate 
proteoglycan that is proposed to serve in cell-cell 
adhesion, cell-matrix anchorage, and growth factor 
signaling. Its expression is temporally and spatially 
regulated during epithelial-mesenchymal interactions in 
many developing tissues. In some cases, this regula- 
tion appears to be achieved at the level of transcrip- 
tion. However, induction of syndecan-1 expression in 
the embryonic kidney mesenchyme is suggested to oc- 
cur at the level of mRNA translation (Vainio,  S., M. 
Jalkanen, M. Bernfield, and L. Saxdn.  1992.  Dev. 
Biol.  152:221-232).  To identify a system in which the 
regulatory mechanisms controlling syndecan-1 expres- 
sion can be studied, cells of the monocyte-macrophage 
lineage, which regulate the expression of many cell 
surface receptors, were screened for syndecan-1 ex- 
pression. The syndecan-1 gene is active in blood 
monocytes as well as resident and thioglycollate- 
elicited mouse peritoneal macrophages, but expression 
of the proteoglycan is regulated at two levels.  First, 
elicited macrophages accumulate nine-fold more 
syndecan-1 mRNA than do resident macrophages or 
circulating blood monocytes. Another member of the 
syndecan family of proteoglycans, syndecan-4, shows a 
distinct pattern of expression, suggesting that this 
regulation is specific for syndecan-1. Second, utiliza- 
tion of the mRNA for syndecan-1 production encoun- 
ters a post-transcriptional block in the elicited macro- 
phages that can be overcome by triggering agents such 
as E-type prostaglandins or dibutyryl cAMP, which 
raise intracellular cAMP levels. Dibutyryl cAMP does 
not induce syndecan-1 expression in resident peritoneal 
macrophages, which lack a pool of stored mRNA. 
This suggests that this agent promotes the post-tran- 
scriptional utilization of stored syndecan-1 mRNA. 
The induced proteoglycan appears at the cell surface 
as a ,x,100-kD heparan sulfate-rich isoform of 
syndecan-1. This suggests that a cAMP-dependent post- 
transcriptional control mechanism may be present in a 
variety of tissues when syndecan-1 expression is regu- 
lated. 
S 
YNDECAN-1 is the prototypical member of a family of 
integral membrane heparan sulfate proteoglycans that 
are expressed in different combinations  by most cell 
types (reviewed by Bernfield et al., 1992). The defining fea- 
tures of these glycoproteins are: (a) highly conserved trans- 
membrane and cytoplasmic domains,  and  (b)  decoration 
with heparan sulfate  glycosaminoglycans.  Although  the func- 
tion  of the cytoplasmic domain is unclear, the presence of 
four invariant tyrosines suggests roles in targeting and/or an- 
chorage to cytoplasmic molecules, such as components of 
coated pits or the cytoskeleton. Indeed, syndecan-1 exhibits 
a polarized distribution along the basolateral surface of epi- 
thelial cells, and is proposed to be anchored to the cytoskele- 
ton (P,  apraeger et al.,  1986). 
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Many of the suggested roles of the syndecans are inferred 
from the biological properties of  heparan sulfate. This glycos- 
aminoglycan  binds  proteins  in  the  extracellular  malrix 
(ECM)  1 such as interstitial collagens, fibronectin, tenascin, 
and thrombospondin,  which suggests that the syndecans may 
serve to anchor cells  to the ECM (Jackson  et al.,  1991; 
Bernfield  et al.,  1992). In addition,  syndecan-1 has been 
identified as a low affinity binding site for basic FGF (Kiefer 
et al., 1990) and heparan sulfate at the cell surface is essen- 
tial for receptor binding  and biological  activities  of FGFs 
(Rapraeger  et al.,  1991; Yayon et al.,  1991; Olwin and 
Rapraeger,  1992). 
Although progress has been made toward elucidating the 
structures  and  activities  of  syndecans,  the  mechanisms 
controlling the expression of  these molecules are not known. 
1. Abbrevian'ons used in this paper: dbcAMP, dibutyryl cAMP; dbcGMP, 
dibutyryl  cGMP;  ECM,  extracellniar  matrix;  LPS,  lipopolysaccharide; 
MO, macrophage. 
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syndecan-1  expression  have been reported.  B  lymphocyte 
progenitors  express the proteoglycan when attached  to the 
stromal matrix of the bone marrow and lose it coordinately 
with their maturation  and release into the circulation  (San- 
derson et al., 1989). Secreting plasma cells regain the mole- 
cule when they become anchored within the interstitial  ma- 
trices of the lymph node and duodenum, and use syndecan-1 
to bind type I collagen in vitro (Sanderson et al., 1989; San- 
derson et al., 1992b). During wound healing, coordinate in- 
duction of syndecan-1 mRNA and proteoglycan expression 
is observed in rapidly proliferating  keratinocytes adjacent to 
wound margins  (Elenius  et al.,  1991). Syndecan-1 expres- 
sion is regulated  both spatially  and temporally during  epi- 
thelial-mesenchymal  interactions  in  the  developing  tooth 
(Vainio et al.,  1991), kidney (Vainio et al., 1992), and limb 
(Solursh et al.,  1990).  In each of these tissues,  syndecan-1 
is transiently  lost from the epithelium  as it changes  shape, 
but regained when this tissue becomes morphologically sta- 
ble. Syndecan-1 is also induced in the proliferating  mesen- 
chyme. In the developing tooth, this appears to involve tran- 
scriptional  activation  of the syndecan-1 gene (Vainio et al., 
1991). In the developing kidney, syndecan-1 is induced in the 
metanephric  mesenchyme by interaction  with the metaneph- 
ric duct (Vainio et al., 1992). A notable characteristic  of this 
induction is that syndecan-1 mRNA is expressed in the unin- 
duced  mesenchyme,  but  not  utilized  until  the  inductive 
period. This suggests that an important mechanism for reg- 
ulating  syndecan-1  expression in the kidney,  and perhaps 
other tissues,  is at the level of mRNA translation. 
Macrophages  provide a useful system to begin studying 
this  important regulatory mechanism.  These cells partici- 
pate in a multitude of interactions  with other cells, the ECM, 
chemical mediators, and pathogens.  Not surprisingly,  mac- 
rophages express roughly 50 types of cell surface receptors, 
many of which are regulated during the development and ac- 
tivation of these cells (Adams and Hamilton, 1984; Gordon, 
1986).  Furthermore,  macrophages  are engaged  in several 
activities  that  likely  require  the  regulated  expression  of 
heparan sulfate proteoglycans,  including  anchorage  to and 
directed migration  through  ECM (Gordon, 1986; Springer, 
1990) and participation  in wound healing  and angiogenesis 
through the production and release of heparan sulfate-bind- 
ing growth factors (Baird et al., 1985; Rappolee et al., 1988; 
Knighton and Fiegel, 1989; Higashiyama et al., 1991; Stein 
and Keshav, 1992). 
In the present study, circulating blood monocytes, resident 
and thioglycollate-elicited  murine peritoneal macrophages 
were screened for syndecan-I  mRNA and proteoglycan ex- 
pression. This analysis revealed that the syndecan-1 gene is 
active in each of these cell types, but the expression of this 
proteoglycan is regulated at two levels. First, the syndecan-1 
mRNA is specifically  accumulated by macrophages  during 
inflammatory  recruitment.  In  contrast,  mRNA  encoding 
syndecan-4  is expressed at the same level by each of these 
cell types, indicating that the induction of syndecan-1 expres- 
sion  is  specific.  Secondly,  utilization  of the  syndecan-1 
mRNA for proteoglycan expression  encounters a post-tran- 
scriptional  block that can be overcome by agents,  such as 
prostaglandin  Ea, that raise intracellular  cAMP levels. The 
mechanism controlling  syndecan-1 expression  during  mac- 
rophage activation  may be indicative  of a mechanism op- 
erative in many cell and tissue types, including  stratifying 
keratinocytes (Sanderson et al., 1992a) and condensing mes- 
enchymal  cells  in  the  developing  kidney  (Vainio  et  al., 
1992), that demand the temporal regulation of  this molecule. 
Materials and Methods 
Reagents 
cDNA probes for mouse syndecan-1  (4-19b) (Sannders et al.,  1989) and 
mouse syndecan-4  (pMB176) were generously provided by Dr.  Merton 
Bernfield (Joint Program in Neonatology, Harvard Medical School, Boston, 
MA). 
Rat mAb 281.2,  specific for the core protein of mouse syndecan-1, was 
isolated as described previously  (Jalkanen et ai.,  1985). Rabbit anti-actin 
serum was  obtained from Sigma Chemical Co.  (St.  Louis,  MO).  Non- 
specific rat IgG,  FITC-conjngated  rabbit anti-rat IgG,  and alkaline phos- 
phatase-conjngated  goat anti-rat and goat anti-rabbit IgGs were purchased 
from Jackson Immunoreseareh (West Grove,  PA). 
Dibutyryladenosine Y:5'-cyclic  monophosphate (dbcAMP), dibutyryl- 
guanosine 3':5'-cyGlic  monophosphate (dbcGMP), PMA, forskolin,  prosta- 
glandins Et and E2, and lipopolysaccharides  (LPS) were obtained from 
Sigma Chemical Co. Cholera toxin was purchased from ICN Biomndicals 
(Irvine, CA).  Interferon-3, (1,000 U/ml) was generously provided by Dr. 
Donna Paulnock (Department of Medical Microbiology, University of Wis- 
consin, Madison, WI). 
Cell Culture 
Mouse (NMuMG) mammary gland epithelial cells were maintained at low 
passage in DME (Gibco Laboratories, Gaithersburg, MD) containing 10% 
(vol/vol) FBS. 
Peripheral blood mononuclear leukocytes  were isolated from mouse 
blood according to Boyum (1968): blood was aspirated via heart puncture 
of anaesthetized male C57B1/6 mice (Harlan Sprague Dawley, Indianapolis, 
IN) and diluted into RPMI-1640  (Oibco Laboratories) containing 20 U/ml 
heparin. Cells were carefully  layered onto histopaque (1.077 g/ml, Sigma 
Chemical Co.) and centrifuged at 400 g for 30 min. The white cell interface 
was collected, washed with medium, and monocytes were isolated by adher- 
ence to tissue culture dishes coated with FBS (Kumagai et al.,  1979). 
Peritoneal exudate  cells were elicited by intraperitoneal injection of 
10-12 wk old male C57B1/6 mice with 1 ml Brewer's thinglycollate  broth 
(Difco, Detroit, MI) 4-5 d before harvesting cells. Resident and thioglycol- 
late-elicited  macrophages  were isolated by peritoneal lavnge with RPMI- 
1640 followed by adherence for 30-60 rain to tissue culture dishes. Adher- 
ent monocytes,  resident and elicited peritoneal macrophages  were washed 
vigorously  with medium after the attachment period. Routinely, >95% of 
the cells were positive for the macrophage-specific  antigen MAC-1 by im- 
munofiuorescent  staining (Ho and Springer,  1984). Primary cultures were 
used for experiments immediately  after their isolation. 
RNA Isolation and Northern Analysis 
The isolation of total and poly(A)  + RNA from cell monolayers  has been 
described previously  (Badley  et al.,  1988;  Sambrook et al.,  1989).  For 
RNA slot blot analysis,  aliquots of 1 #g/lane poly(A)  + RNA were applied 
to a nitrocellulose membrane (Schleicher and Shull, Inc., Keene, NH) and 
baked. For Northern analysis, aliquots of 5 ~g of  total RNAJlane were sepa- 
rated on a formaldehyde-containing  1% agarnse gel by electrophoresis at 
40 V overnight and blotted onto a Nytran membrane (Schleicber and Shull, 
Inc.). 
Blots were sequentially probed with the 1.4-kb EcoRI-HindIII fragment 
from the 4-19b syndecan-1 eDNA, the 368-bp BamHI-EcoRl fragment from 
the pMB176 syndecan-4  eDNA,  and the  1.3 kb Pstl fragment from the 
pGPDN5  GAPDH eDNA.  Inserts were oligolabeled  with [~-32p]dCTP 
(>3,000 Ci/mmol, DuPont, Wilmington, DE) using the Prime-a-Gene sys- 
tem (Promega Corp., Madison, WI), and isolated on columns of Sephadex 
G-50 (Pharmacia LKB Biotechnology  Inc., Piscataway, NJ) (Sambrook et 
al.,  1989). 
Blots were prehybridized at 42°C for 4 h in 50% formamide,  5x Den- 
hardt's,  0.1% SDS,  5×  SSPE,  and  100 ~tg/ml denatured salmon sperm 
DNA. Hybridization was performed at 42°C for 16 h in the same buffer con- 
taining 2.5× Denhardt's and 106-107 cpm/m132p-oligolabeled eDNA. The 
membranes were washed in 6× SSPE, 0.5%  SDS at room temperature (2 
The Journal of Cell Biology, Volume 122, 1993  942 ×  15 min), and in  lx  SSPE,  0.5%  SDS  at 60°C  (1  x  60 min).  The 
0.24-9.5-kb RNA ladder (Bethesda Research Laboratories, Gaithersburg, 
MD) was used to determine the molecular size of the hybridizing RNA 
species. 
Isolation of  Proteoglycans and Digestion 
of  Glycosaminoglycans 
Confluent cell monolayers were lysed and sonified in 8 M urea, 0.2 % Triton 
X-100,  10 mM Tris-HC1, pH 8.0 containing protease inhibitors. DEAE- 
Sepbacel (Pbarmacia LKB Biotechnology) was combined with lysates (100 
/LI per 107 cells) and mixed overnight at 4"C. Beads were washed with TBS 
and eluted with 1 M NaCI in heparitinase digestion buffer (100 mM HelaeS, 
pH 6.5, 10 mM CaCI2, 0.5% CHAPS, 0.2 mg/ml BSA). Eluted proteogly- 
can samples were collected as described (Sanderson et al.,  1992b). 
Enzymatic cleavage of heparan sulfate  and chondroitin sulfate  glycos- 
anainoglycan chains was achieved by diluting proteoglycan samples 2x with 
ddH20 followed  by incubation twice for 2  h  at 37"C with 1 mU/ml of 
heparinase HI 0teparitinase, ICN Biochemicals, Cleveland, OH), or with 
50 mU/rnl of chondroitinase ABC (ICN Biomedicals), or with both en- 
zymes. 
Gel Electrophoresis and Immunoblotting 
Electrophoresis of proteoglycan samples was performed in SDS-polyacryl- 
amide gradient (3.5-15%  T; 7.5% C) gels in TrisHCl/Borate buffer, pH 8.8 
(Koda et al.,  1985).  Electrophoresis of proteoglycan core protein samples 
was performed as described by Laemmli (1970) in 7 % SDS-polyacrylamide 
gels. Samples were then electroblotted onto cationic nylon (Zeta Probe-GT, 
BioRad, Rockville Center, NS0 at 60 V for 4 h. Membranes were fixed with 
0.05% glutaraldehyde in PBS for 30 rain (Sanderson et al., 1989). Blocking 
was achieved by incubation for at least 2 h at 37"C in TBS containing 5% 
nonfat powdered  milk, 25/Lg/ml hepadn, and 0.02 % sodium azide. 
Blots were probed for syndecan-I  by incubation with 1/~g/ml mAb 281.2 
in TBS containing 5 % non-fat powdered  milk (Blotto) for 2  h at 37"C. 
Membranes were washed 5  ×  10 win with TBS containing 0.1% NP-40, 
once for 10 rnin in blotto, then further incubated for 60 rain in blotto con- 
taining alkaline phospbatase-conjugeted goat anti-rat IgG (1:3,000). After 
washing as above,  blots were incubated 10 rain in alkaline phosphatase 
buffex (100 mM NaC1, 5 mM MgCl2,  100 rnM Tris HCI, pH 9.5). Finally, 
the membranes were incubated at 37°C for 5-10 rain in LumiPhos chemilu- 
min~cent substrate (Boehringer Mannheim, Indianapolis, IN) and exposed 
to x-ray  film (Kodak XAR-5). 
lmmunostaining 
Immunolocalization of syndecan-1 was done with mAb 281.2.  Resident or 
thioglycollate-elicited  mouse peritoneal macroplmges were cultured 9 h on 
glass coverslips  in the absence or presence of 1 mM dibutyryl cAMP, 
washed,  then fixed in 4% fommldehyde.  For permeab'dization,  cells were 
extracted in 0.2% Triton X-100 for 5 min at room temperature.  Cells were 
blocked in PBS containing 10% bovine serum and incubated 30 min with 
25 ttg/rnl mAb 281.2 or nonspecific  rat IgG in the same.  After thorough 
washing,  cells were incubated 30 rain with F1TC-rabbit anti-rat IgG (1:40 
in PBS containing 10% bovine serum). After washing fivefold with PBS, 
coverslips were mounted on glass sfides in lmmumount (SImndon Southern 
Instruments, Inc., Sewickley, PA) and viewed on a Nikon Microphot-FX 
microscope. Cells incubated with nonspecific  rat IgG showed no staining. 
Pictures were recorded on Kodak Tri-X Pan film exposed  at ASA 800. 
Results 
Elicited Peritoneal Macrophages Accumulate 
Syndecan4 mRNA 
Mouse blood monocytes,  resident peritoneal macrophages, 
and  thioglycollate-elicited  peritoneal  macrophages  were 
screened for syndecan-1 mRNA in an initial effort to deter- 
mine whether expression  of this heparan sulfate proteogly- 
can  is  regulated  during macrophage  activation.  Slot blot 
analysis of poly A + RNA reveals that the syndecan-1 gene is 
active  in all three cell populations  (Fig.  1).  However, the 
level  of expression  is  dramatically  different.  Circulating 
Figure L  Syndeean-1 mRNA accumulates in thioglycollate-elicited 
peritoneal macrophages. Approximately 1 gg poly A ÷ RNA from 
cultured  NMuMG  cells,  blood monocytes,  resident and elicited 
mouse  peritoneal  macrophages  was  applied  to  a  nitrocellulose 
membrane. The blot was probed with a  1.4-kb EcoRI-Hindl/I frag- 
ment of the 4-19b syndecan-1 eDNA and washed in 1 x  SSPE plus 
0.5%  SDS at 60"C.  After autoradiography, the blot was stripped, 
reprobed with a  1.3-kb Pstl fragment of the pGPDN5  cDNA en- 
ceding glyceraldehyde phosphate dehydrogenase (GAPDH),  and 
washed as above.  Scanning densitometry was performed and the 
relative abundance of syndeean-1 mRNA calculated after correcting 
for loading differences between samples. 
blood monocytes express only low levels of the mRNA. The 
proteoglycan is also expected to be scarce in these cells, as 
monocytes from a variety of sources reportedly lack heparan 
sulfate  proteoglycans  (Kolset  and  Gallagher,  1990).  The 
resident peritoneal macrophages  also express low levels of 
the  transcript,  similar  in amount to the peripheral  blood 
monocytes. In contrast,  macrophages recruited to the perito- 
neal cavity during  thioglycollate-induced  infammafion ex- 
press '~ninefold higher levels of syndecan-1 mRNA. Indeed, 
the  elicited peritoneal  macrophages  accumulate  as  much 
syndecan-1  mRNA as NMuMG mammary epithelial  cells 
(Fig.  1), which express ",,106 copies per call of this heparan 
sulfate proteoglycan (Rapraeger et al., 1985; Jalkanen et al., 
1985).  Finally,  elevation  of syndecan-1  mRNA  levels  in 
elicited macrophages reflects the coordinate accumulation of 
two transcripts  of 2.6 and 3.4 kb (Fig. 2). Thus,  the macro- 
phages express both mRNA species associated with  syn- 
decan-1 production in other cell types. 
The regulation of syndecan mRNA accumulation that ac- 
companies  peritoneal  macrophage  recruitment  during  in- 
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pression during macrophage activation. Total RNAs (5 #g) from 
cultured NMuMG cells, blood monocytes, resident and thioglycol- 
late-elicited peritoneal maerophages were size-separated, trans- 
ferred to a nylon filter, and probed with a 1.4-kb EcoRI-Hindm 
fragment of the 4-19b syndecand eDNA and washed in 1 x  SSPE 
plus 0.5% SDS  at  60°C. After  autoradiography, the  blot  was 
stripped, reprobed with a 368-bp BamI-II-EcoRI fragment of the 
pMB176 syndecan-4  eDNA  and washed  as above. Sizes of  hybridiz- 
ing RNA molecules were determined by comparison with a 0.24- 
9.5-kb RNA ladder. This identified two syndecan-1 transcripts, at 
3.4 and 2.6 kb, and a single 2.6-kb syndecan-4 transcript. 
flammation appears to be specific for syndecan-1.  Another 
member  of the  syndecan family, syndecan-4,  is  also  ex- 
pressed by cells of the monocyte-macrophage lineage; sev- 
erai  macrophage-like  cell  lines  accumulate  syndecan-4 
mRNA, and this is the sole detectable heparan sulfate pro- 
teoglycan expressed at the surface of P388D1  macrophage- 
like  cells  (Yeaman  and  Rapraeger,  1993).  To  determine 
whether primary cultures of monocytes and macrophages 
express syndecan-4 mRNA and whether its expression mir- 
rors that of syndecan-1,  northern analysis for each of these 
core protein transcripts was performed. In addition to the 
characteristic syndecan-1  transcripts, blood monocytes and 
resident  peritoneal  macrophages  accumulate  a  2.6  kb 
syndecan-4 transcript (Fig. 2). This mRNA is also expressed 
by elicited peritoneal macrophages. However, in contrast to 
syndecan-1,  the abundance of syndecan-4 mRNA remains 
relatively uniform after macrophage recruitment. After cor- 
recting for loading differences  between samples, densitomet- 
ric scanning reveals that the level of syndecan-4 mRNA in 
the elicited macrophages decreases to 80% of the level in the 
resident macrophages. However,  this occurs as syndecan-1 
mRNA undergoes a '~ninefold increase in the elicited mac- 
rophages. Therefore, syndecan-1 is specifically accumulated 
by elicited peritoneal macrophages, suggesting that expres- 
sion of individual members of this proteoglycan family are 
differentially regulated. 
Elicited Peritoneal Macrophages Do Not Express 
Syndecan-1 Proteoglycan 
Elicited  peritoneal  macrophages  and  NMuMG  epithelial 
cells accumulate similar amounts of syndecan-1 mRNA (Fig. 
1). In the NMuMG cells, mRNA expression is coupled to the 
production of high levels of this proteoglycan, which is lo- 
cated predominantly at the cell surface (Fig. 3; Rapraeger et 
al., 1985; Jalkanen et al., 1985).  We anticipated, therefore, 
that the elicited macrophages would express high levels of 
syndecan-1 at the cell surface. Yet attempts to isolate the pro- 
teoglycan have shown little, if any, accumulation of this tool- 
Figure 3. Dot immunoassay for syndecan-1 protein in cultures of 
NMuMG epithelial  cells and thioglycollate-elicited  peritoneal mac- 
rophages.  NMuMG  cells  and  thioglycollate-elieited peritoneal 
macrophages were cultured for 24 h then extracted in 8 M urea plus 
1% Triton X-100 for analysis of syndecan-1 in whole cell lysates. 
Alternatively,  cells were incubated with 25 t,g/ml trypsin on ice for 
10 min to remove cell surface material before extraction. Serial 
threefold dilutions of whole ceil lysates, trypsin-released material 
(cell surface), material remaining with the cells (intracellular), and 
material accumulated in the culture medium were applied to a cat- 
ionic nylon membrane. The blot was blocked and  probed for 
syndecan-1 with mAb 281.2 as described in Materials and Methods. 
The first dot in each row of samples represents material obtained 
from 10  ~ cells. 
ecule in these cells. Macrophage cell lysates are negative in 
dot immunoassays that detect 100-fold less syndecan-1  than 
that in the NMuMG cells (Fig. 3).  Furthermore, immuno- 
staining of cells permeabilized with Triton X-100 shows that 
neither syndecan-I proteoglycan nor nascent core protein is 
present in the macrophages (Fig. 6 b). Finally, the proteogly- 
can does not accumulate in the culture medium of macro- 
phages, suggesting that it is not rapidly shed from the cell 
surface (Fig. 3).  Thus, although inflammatory recruitment 
of macrophages into the peritoneal cavity is accompanied by 
an accumulation of syndecan-1  transcript, the macrophages 
do not appear to translate this mRNA into protein. 
Exogenous dbcAMP Triggers the Expression of 
Syndecan-1 by Elicited Peritoneal Macrophages 
Because elicited peritoneal macrophages fail to express syn- 
decan-1 despite accumulating abundant mRNA, it is possible 
that the cells require an additional triggering signal for pro- 
teoglycan production. A  variety of macrophage activation 
agents and second messenger analogs were screened for the 
ability to induce syndecan-1  expression in the macrophages 
(data not shown). This identified dbeAMP as such a trigger. 
The membrane-permeable cAMP analog induces production 
of a  proteoglycan that reacts  with rnAb  281.2,  which  is 
specific for syndecan-1  (Jalkanen et al.,  1985).  The macro- 
phage isoform of syndecan-1  migrates in a heterodisperse 
distribution during SDS-PAGE, with a median mass of ~100 
kD compared to protein standards, and is thus smaller than 
the 160-kD form expressed by NMuMG epithelial cells (Fig. 
4).  Syndecan-1  produced by macrophages bears predomi- 
nantly, if not exclusively, heparan sulfate glycosaminoglycan 
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by elicited peritoneal macrophages. Thioglycollate-elicited perito- 
neal macrophages were cultured in the presence of I mM d~.AMP 
for 9  h.  Proteoglycans were  isolated  from NMnMG  cells  and 
dbcAMP-treated  macrophages  as  described  in  Materials  and 
Methods. After digestion without or with heparinase HI (Hephse) 
and/or chondroitinase ABC (Chonhse), samples corresponding to 
'~4 ×  I(Y  s cells/lane were fractionated by electrophoresis in SDS- 
polyacrylamide gradient gels and transferred to a Zeta Probe-GT 
cationic nylon membrane. The membrane was fixed, blocked, and 
probed for syndecan-1 with mAb 281.2 as described in Materials 
and Methods. Nondigested syndecan-1  migrates in a heterodisperse 
distribution, with a median mass of"o160 kD in NMuMG cells and 
100 kD in macrophages, compared with protein standards. Enzy- 
matic digestion of glycosaminoglycan chains reveals the same ,,°80 
kD core protein in each cell type. 
chains, as treatment with heparitinase reduces its size to a 
core protein of ,o80 kD, identical in size to the core protein 
expressed by the NMuMG cells. Treatment with chondroi- 
tinase ABC has little, if any, effect on this proteoglycan (Fig. 
4). Therefore, treatment of elicited peritoneal macrophages 
with dbeAMP promotes the expression of syndecan-1 bear- 
ing primarily heparan sulfate glycosaminoglycan chains. 
To define the optimal conditions to employ dbcAMP, it was 
desirable  to  remove  the  glycosaminoglycan chains  from 
syndecan-1  before electrophoresis because the intact pro- 
teoglycan is  heterodisperse and  difficult to  visualize and 
quantify on immunoblots. Furthermore, the core protein has 
a defined size which is diagnostic for syndecan-1, especially 
when detected by mAb 281.2, which is specific for this core 
protein. Therefore, intact proteoglycan  was isolated on DEAE 
Sephacel beads and treated with heparitinase prior to SDS- 
PAGE and  immunoblotting as  described in  Materials  and 
Methods. 
Dibutyryl cAMP appears  to induce the utilization of a 
stored pool of syndecan-1 mRNA in elicited peritoneal mac- 
rophages. Macrophages cultured in the absence of  the analog 
for up to 48 h fail to express detectable amounts of syndecan- 
1 proteoglycan (not shown). However, macrophages exposed 
to dbcAMP 2 h after their isolation (Fig. 5) or following 26 
h in culture (not shown), are rapidly stimulated to express 
the proteoglycan. The induction of syndecan-1 expression by 
dbcAMP  is both dose- and time-dependent.  Treatment of 
macrophages with 100/~M dbeAMP induces production of 
syndecan-1, but the abundance of the proteoglycan increases 
substantially with tenfold higher concentrations of the ana- 
log (Fig. 5 A). Because 1 mM dbcAMP is at the upper end 
Figure 5. Induction of syndecan-1 expression by dbcAMP is dose- 
and time-dependent. In A, elicited peritoneal macrophages were 
cultured for 9 h in the presence of increasing concentrations of 
dbcAMR as indicated. In B, the cells were cultured in the presence 
ofl mM dbcAMP for 0, 3, 6, 9, or 12h. Actin abundance in macro- 
phages cultured 9 h in the absence or presence of I mM dbcAMP 
was assessed by immunoblot analysis with a polyclonal anti-actin 
antiserum (1:1,000)  after electrophoresis of  whole cell lysates in 7 % 
acrylamide gels. For quantification of syndecan-1 expression, pro- 
teoglycans were isolated from equal numbers of cells (2.5  ×  106 
cells/lane)  and  digested with heparinase  HI and chondroitinase 
ABC as described in Materials and Methods. Samples were frac- 
tionated by electrophoresis in 7% SDS-polyacrylamide gels and 
transferred to cationic nylon. Membranes were fixed, blocked, and 
probed for syndecan-1 with mAb 281.2 as described in Materials 
and Methods. In panel B, scanning densitometric analysis was per- 
formed and the relative abundance of syndecan-1 in each lane was 
calculated. Note that the abundance of actin is unchanged under 
conditions in which syndecan-1 induction is maximal,  indicating 
that the d~AMP treatment does not promote a global increase in 
protein synthesis in the macrophages. 
of concentrations employed in cell regulation studies, higher 
concentrations were not tested. However, this concentration 
induces  syndecan-1  expression on  macrophages  to  levels 
similar to those observed on NMuMG cells (cf. Fig. 4). 
Kinetic analysis of syndecan-1 induction reveals that the 
abundance of the proteoglycan increases in a linear fashion, 
after a 3-h lag, and reaches maximal levels 9 h after addition 
Yeaman and Raptaeger  Regulation of Syndecan-I Expression  945 Figure 6.  Immunolocalization of syndecan-1  with mAb 281.2.  Thioglycollate-elicited  mouse peritoneal macrophages were cultured for 
9 h in the absence (A, B) or presence (C-F) of 1 mM dbcAMP. Cells were fixed in PBS containing 4% formaldehyde. In A-D, cells were 
permeabilized  with 0.2 % Triton X-100 for 5 rain after fixation. Syndecan-1 was stained in B, D, and F by incubation of cells with 25 #g/ml 
mAb 281.2 followed by a 1:40 dilution of FITC-conjugated rabbit anti-rat IgG. Note that syndecan-1  stains intensely around the perimeter 
of dbcAMP-treated macrophages, but is also detected in an intracellular location in panel d, possibly reflecting proteoglycan in the Golgi 
apparatus. Controls incubated with 25 #g/ml non-specific rat IgG showed no staining (not shown). Corresponding bright field micrographs 
are shown in A, C, and E, respectively. Bar, 50 #m. 
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exposed to dbcAMP for 12 h reproducibly show reduced ex- 
pression of syndecan-1  compared with cells stimulated for 
9 h  (Fig. 5 B).  Therefore, for routine induction of synde- 
can-1  expression, elicited peritoneal macrophages are cul- 
tured for 9 h in the presence of 1 mM dbeAMP. 
To determine the distribution of syndecan-1  in the macro- 
phage cultures, cells were incubated for 9 h in the absence 
or presence  of 1 mM dbcAMP and immunostained with 
mAb 281.2 (Fig. 6). This verified that elicited macrophages 
fail to express the proteoglycan unless they are triggered with 
the cAMP analog (compare Fig. 6, B with D). Macrophages 
cultured in the presence of dbcAMP show intense staining 
for syndecan-1 which is distributed primarily around the pe- 
rimeter of the cell (Fig. 6, D and F). Permeahilization with 
0.2% Triton X-100 reveals additional syndecan-1  located in 
a perinuclear distribution, presumably reflecting the Golgi 
apparatus (Fig. 6 D). However, the bulk of the proteoglycan 
is visible in nonpermeabilized cells (Fig. 6 F), indicating 
that it is located at the cell surface. Furthermore, no cell is 
visible that shows intracellular staining that does not also 
show cell surface staining. This indicates that syndecan-1  is 
not stored intracellularly in the macrophages. 
Dibutyryl cAMP promotes the expression of syndecan-1 in 
most, but not all of the macrophages in the culture (compare 
Fig. 6 C with D). Roughly 25 % of the cells fail to express 
syndecan-1.  Because cultures are typically 95 % pure as as- 
sessed by Mac-1  staining, the cells which fail to express 
syndecan-1  likely reflect a  sub-population of macrophages 
which does not respond to the inductive signal employed 
here. These may be resident macrophages which were pres- 
ent in the peritoneal cavity before the inflammatory recruit- 
ment or a subset of elicited macrophages that does not ex- 
press syndecan-1  in response to dbcAMP. 
Stimulation of syndecan-1  expression by dbcAMP is spe- 
cific for elicited peritoneal macrophages. Resident perito- 
neal macrophages do not respond. As expected, these cells, 
which lack a substantial pool of syndecan-1  mRNA, fail to 
express detectable levels of  this proteoglycan (Fig. 7 A). Fol- 
lowing exposure to 1 mM dbcAMP for 9 h, these cells re- 
main negative for syndecan-1  expression (Fig.  7  B).  Pro- 
longed exposure to dbcAMP for 18, 24, or 36 h also fails to 
induce syndecan-1  expression (data not shown). This sug- 
gests that dbcAMP affects primarily the utilization of stored 
mRNA in the elicited peritoneal macrophages, rather than 
stimulating transcription of novel mRNA. 
Syndecan-1 Is Induced by Agents that Raise 
IntraceUular cAMP Levels 
The effect of dbcAMP suggests that agents that cause an ele- 
vation of intracellular cAMP specifically induce syndecan-1 
expression. This was verified by culturing elicited peritoneal 
macrophages in the presence of cholera toxin and forskolin, 
which raise cAMP concentrations in the cell by different 
mechanisms.  Both reagents induce syndecan-1  expression 
(Fig. 8). In contrast, dbcGMP, though chemically similar to 
dbcAMP, fails to promote syndecan-1  expression. Further- 
more, stimulation of protein kinase C by the phorbol ester 
PMA also fails to trigger production of this proteoglycan 
(Fig. 8). Therefore, the expression of cell surface syndecan-1 
appears  tightly regulated by agents that raise intracellular 
cAMP levels. 
Figure 7.  Resident peritoneal macrophages do not express syn- 
decan-1 in response to dbcAME Resident mouse peritoneal macro- 
phages were cultured for 9 h in the absence (A) or presence (B) of 
1 mM dbcAME Cells were fixed in PBS containing 4% formalde- 
hyde. Syndecan-1  expression was evaluated by incubation of non- 
permeabilized cells with 25/~g/ml mAb 281.2 followed by a 1:40 
dilution of F1TC-conjugated  rabbit anti-rat IgG. Note that resident 
peritoneal macrophages, which lack a large pool of syndecan-1 
mRNA, fail to express syndecan-1 in response to dbcAME Con- 
trols incubated with 25/zg/ml nonspecific rat IgG appear similar 
to those incubated with mAb 281.2 (not shown). Bar, 50/~m. 
Elicited Peritoneal Macrophages  Express Syndecan-I 
in Response to Prostaglandins 
To determine whether syndecan-1  expression is induced by 
physiologically relevant agents,  elicited peritoneal macro- 
phages were cultured in the presence of E-type prostaglan- 
dins. Macrophages produce and respond to prostaglandins 
in vivo (Zwilling and Justement,  1988).  Furthermore, the 
effects of  E-type prostaglandins on macrophage activities are 
believed to be mediated through a cAMP signaling pathway 
(Zwilling and Justement, 1988).  Therefore, it is not surpris- 
ing that prostaglandin E2 stimulates syndecan-1  proteogly- 
can expression by elicited peritoneal macrophages in a dose- 
dependent manner (Fig. 9 A).  The inductive effect of this 
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sion  by  elicited  peritoneal 
macrophages  is  specifically 
induced  by  pharmacological 
agents that raise  intracellular 
cAMP levels. Thioglycollate- 
elicited mouse peritoneal ma- 
crophages  were  cultured  for 
9 h in the absence or presence 
of 1 mM dbcAMP or  1 mM 
dbcGMP or  for  12  h  in  the 
presence of cholera toxin (10 nM), forskolin (100 ttM), or the phorbol ester PMA (100 nM). For analysis of syndecan-1 expression, pro- 
teoglycans were isolated from equal numbers of cells (2.5  x  106 cells/lane)  and digested with heparinase  HI and chondroitinase  ABC 
as described in Materials and Methods. Samples were fractionated by electrophoresis in 7 % SDS-polyacrylamide gels and transferred to 
cationic nylon. Membranes were fixed, blocked,  and probed for syndecan-1 with rnAb 281.2 as described  in Materials  and Methods. A 
range of PMA concentrations  (10-1000 nM) failed to stimulate syndecan-1 expression by these cells (not shown). 
agent can be seen at concentrations as low as 10 nM, but in- 
creasing concentrations, up to 10 #M, promote increasingly 
higher levels of syndecan-1 expression. This effect is not re- 
stricted to prostaglandin E2. Treatment of rnacrophages with 
prostaglandin E1  (1 ttM) induces syndecan-1 expression as 
effectively as the equivalent concentration of prostaglandin 
E2  (Fig.  9  a).  In contrast,  potent  macrophage activation 
agents such as interferon-% added alone or in combination 
with LPS, fail to induce expression of syndecan-1 (Fig. 9 B). 
Therefore, macrophages are not stimulated to express this 
proteoglycan by all activating agents.  Rather,  the  stimula- 
tion appears to be specific for a certain class of mediators, 
the E-type prostaglandins,  that elevate intracellular cAMP 
levels. 
Discussion 
Syndecan-1  is expressed on a  variety of cell types and has 
been proposed to be regulated at both the mRNA and protein 
levels (reviewed by Bernfield et al.,  1992).  In this  study, 
maturing macrophages were employed as a model system to 
begin investigating the mechanisms controlling syndecan-1 
expression.  Macrophages  responding  to  an  inflammatory 
signal in the peritoneal cavity express abundant syndecan-1 
mRNA compared to resident peritoneal macrophages and 
blood monocytes. This transcript is not utilized,  however, 
suggesting the presence of a post-transcriptional block. Ex- 
pression of this heparan sulfate proteoglycan is triggered by 
agents that increase intracellular cAMP levels. These include 
Figure  9.  E-type prostaglan- 
dins  induce  syndecan-1  ex- 
pression by elicited peritoneal 
macmphages.  Thioglycollate- 
elicited  mouse  peritoneal 
macrophages  were  cultured 
for  12  h  in  the  absence  or 
presence of dbcAMP, prosta- 
glandin  E2  (PGE2),  prosta- 
glandin  E1  (PGE1), LPS  or 
interferon-3, at the concentra- 
tions  indicated.  Some  cells 
were cultured in the presence 
of  increasing  concentrations 
of interferon-3, plus  LPS (10 
~tg/ml).  For  analysis  of 
syndecan-I  expression,  pro- 
teoglycans were isolated from 
cell lysates and digested with 
heparinase  HI  and  chon- 
droitinase  ABC  as described 
in  Materials  and  Methods. 
Samples  were  fractionated 
by  electrophoresis  in  7% 
SDS-polyacrylamide gels and 
transferred  to  cationic  ny- 
lon.  Membranes  were  fixed, 
blocked,  and  probed  as 
described  in  Materials  and 
Methods. 
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cholera toxin,  and physiologically relevant agents,  such as 
prostaglandins E1 and E2. The mechanism controlling syn- 
decan-1 expression in the macrophage may serve to regulate 
the expression of this proteoglycan in other tissues, such as 
the embryonic kidney mesenchyme, where the accumulation 
of syndecan-1 mRNA and proteoglycan is uncoupled. 
Syndecan-1 and Syndecan-4 mRNAs Accumulate 
Independently During Macrophage  Activation 
Syndecan-1  expression during peritoneal macrophage acti- 
vation is regulated at two levels: (a) accumulation of mRNA 
and (b) synthesis of the proteoglycan core protein. The mac- 
rophages that invade the peritoneal cavity during inflamma- 
tion express ninefold higher levels of syndecan-1 mRNA than 
the population of macrophages that resides in the cavity dur- 
ing homeostasis. Because blood monocytes contain only low 
levels of the transcript, it is likely that invading macrophages 
encounter a signal during their extravasation into the injured 
tissue which promotes the accumulation of this mRNA. The 
nature of such a signal, as well as the mechanism responsible 
for  elevating  syndecan-1  mRNA  levels  are  presently  un- 
known, but may involve regulation at the level of transcrip- 
tion or mRNA stability. 
Although syndecan-1  mRNA levels in elicited macrophages 
are an order of magnitude higher than those in resident mac- 
rophages, we do not detect a corresponding increase in syn- 
decan-4 mRNA after inflammatory macrophage recruitment. 
The levels of this transcript are roughly the same in mono- 
cytes, resident, and elicited peritoneal rnacrophages. Further- 
more, treatment of the elicited macrophages with dbeAMP 
results  in a  *threefold  increase  in the abundance  of syn- 
decan-1 mRNA in elicited peritoneal macrophages,  but has 
no effect on the level of syndecan-4 transcript in these cells 
(unpublished data). These results imply that (a) although the 
macrophages  already  express  at least one heparan  sulfate 
proteoglycan,  they  specifically  induce  syndecan-1,  which 
likely serves an important  role on these cells at a defined 
point in their development; and (b) different members of the 
syndecan family of proteoglycans are regulated by distinct 
mechanisms. 
A Post-transcriptional  Mechanism Regulates 
Syndecan4 Expression in Peritoneal  Macrophages 
Despite the expression of abundant syndecan-1 mRNA, how- 
ever,  the  proteoglycan  is  not  detected  in  elicited  macro- 
phages.  One explanation  for this finding is that syndecan-1 
may be rapidly metabolized, via shedding from the cell sur- 
face or internalization and degradation. However, syndecan-1 
is not recovered in the conditioned medium of macrophages. 
If it were degraded, it would have to be extremely rapid. On 
NMuMG cells, syndecan-1 exhibits a half-life of ,06 h (un- 
published data).  Because macrophages accumulate at least 
100-fold less syndeean-1 than NMuMG cells, the proteogly- 
can would have to exhibit a turnover time of <5 min to ac- 
count for its absence from these cultures if the translational 
efficiency of syndecan-1 mRNA were the same in these two 
cell types. Thus, it is likely that macrophages simply do not 
translate the syndecan-1 mRNA. 
The  syndecan-1  transcript  that  accumulates  in  macro- 
phages during inflammatory recruitment appears to be a la- 
tent pool of mRNA awaiting a signal to trigger its utilization. 
In this respect, the macrophage is analogous to uninduced 
mesenchymal cells during kidney development,  which ap- 
pear to store syndecan-1 mRNA and utilize it for proteogly- 
can expression only after induction by the metanephric duct 
(Vainio et al.,  1992). Elicited macrophages also store syn- 
decan-1  mRNA. Comparison with NMuMG cells, which are 
noted  for expressing  high  levels of syndecan-1,  reveals  a 
similar accumulation of this transcript in the two cell types, 
yet the macrophages fail to express the proteoglycan.  Fur- 
thermore, the macrophages can be cultured for at least 48 h 
without detectable expression of syndecan-1  proteoglycan 
(unpublished data). However, within 3-6 h after exposure to 
dbcAMP, the proteoglycan accumulates in macrophages to 
a level approaching that in NMuMG cells. This suggests that 
the utilization  of syndecan-1  mRNA for proteoglycan pro- 
duction  is  rapidly  stimulated  by elevation of intracellular 
cAMP levels. 
The mechanism by which dbcAMP induces syndecan-1 ex- 
pression is not known, but is likely to involve activation of 
cyclic AMP-dependent  protein  kinases  (PKA) rather  than 
transcriptional  activation of syndecan-1.  Northern  analysis 
reveals a "0threefold increase in syndecan-1 mRNA levels in 
macrophages following a 12 h exposure to dbeAMP (unpub- 
lished data). However, the abundance of the proteoglycan in- 
creases more than 100-fold in response to dbcAMP, suggest- 
ing that the analog acts primarily  at a post-transcriptional 
level. Furthermore, resident peritoneal macrophages, which 
lack a pool of stored mRNA, do not respond to dbcAMP. It 
is tempting to speculate that the 5"untranslated region of the 
syndecan-1  mRNA  regulates  the  translation  of this  tran- 
script. A similar mechanism has been proposed for the regu- 
lation of ornithine decarboxylase mRNA translation (Grens 
and Schefller,  1990; Manzella and Blackshear,  1990).  The 
Y-untranslated  region of syndecan-1  mRNA is 70%  G/C- 
rich (Saunders et al.,  1989) and is predicted to form stable 
secondary structures,  which may impede  scanning  by the 
40S ribosomal subunit (Kozak, 1991).  Elevation of intracel- 
lular  cAMP  levels  and  subsequent  stimulation  of cAMP- 
dependent protein kinases may activate a "translation factor  7 
which serves to melt secondary structures in the syndecan-1 
mRNA,  thus allowing the initiation  of translation. 
Syndecan-1 expression in other tissues also shows a high 
level of regulation.  For instance,  syndecan-1 is temporally 
regulated during differentiation of B lymphocytes (Sander- 
son et al.,  1989). Stratifying keratinocytes change both the 
structure and abuhdance of the proteoglycan, although the 
level of syndecan-1  mRNA does not change (Sanderson et 
al.,  1992a).  Syndecan-1  exhibits temporal  as well as cell- 
type specific regulation during  epithelial-mesenchymal  in- 
teractions in development (Solursh et al., 1990; Vainio et al., 
1991,  1992).  The proteoglycan is transiently lost from the 
epithelium as it changes shape, but regained when this tissue 
becomes morphologically stable. Syndecan-1 is also induced 
in the proliferating  mesenchyme.  In the developing kidney 
this  appears  to  involve  post-transcriptional  activation  of 
stored  mRNA  (Vainio  et  al.,  1992).  The  regulation  of 
syndecan-1 during macrophage development appears also to 
involve the accumulation and post-transcriptional  activation 
of  latent  mRNA.  Therefore,  the  molecular  mechanisms 
responsible  for  syndecan-1  regulation  in  the  macrophage 
may reflect a widespread process controlling the expression 
of this molecule in a variety of cell and tissue types. 
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Note Added in Proof: Kirjavainen et al. have recently shown that synde- 
can-1 expression is translationally suppressed in Ha-ras-transformed epi- 
theliai cells (Kirjavainen, J., S.  Lepp~, N.  E.  Hynes, and M.  Jalkanen. 
1993. Mol.  Biol.  Cell.  In press). 
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